Drawing for PROPYLAMYLATIN

USPTO serial 90430374

PROPYLAMYLATIN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
COHEN, ROBERT ANDREW
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PROPYLAMYLATIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott H. Blackman

Scott H. Blackman FULLER IP LAW LLC4949 E Van Buren St #60682Phoenix, AZ 85082-8635United States

Goods and services

ClassDescriptionStatusFirst use
005veterinary preparations for the treatment of bacterial infections, viral infections, fungal infections, protozoal diseases, and parasite conditions; pharmaceutical preparations for treatment of bacterial infections, viral infections, fungal infections, protozoal diseases, and parasite conditions; anti-parasitic pharmaceutical preparations; anti-parasitic preparations for veterinary use; veterinary preparations, namely, anti-parasitic products for veterinary use; pharmaceutical products and preparations for the prevention and treatment of infectious or parasitic diseases; anti-protozoal pharmaceutical preparations; anti-protozoal pharmaceutical agents for veterinary use; anti-bacterial pharmaceutical preparations; anti-bacterial pharmaceuticals for veterinary use; anti-viral pharmaceutical preparations; anti-viral pharmaceuticals for veterinary use; anti-fungal pharmaceuticals; anti-fungal pharmaceuticals for veterinary use; anti-protozoal pharmaceuticals; anti-protozoal pharmaceuticals for veterinary use; anti-infective pharmaceutical preparations; anti-infective pharmaceutical preparations for veterinary use; anti-microbial pharmaceutical preparations; anti-microbial pharmaceutical preparations for veterinary use; pharmaceutical preparations for treatment and prevention of infectious diseases; veterinary preparations for treatment and prevention of infectious diseases; antimicrobial preparations and substances for the prevention, inhibition, treatment, and disinfection of bacterial, fungal, and other microbial infections, microbial conditions, and microbial growth in or near humans and animals and their environs, including maintaining hygiene in and on surfaces and materials for preparation of food and beverages, waste accumulation and disposal, and in living and work spaces; pharmaceutical preparations for the inhibition of bacterial, fungal and microbial activity, and for the prevention and treatment of bacterial, fungal and microbial infections in humans and animals; anti-fungal preparations for medical use; pharmaceutical preparations and substances for the treatment of viral and respiratory related diseases and disorders; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria; probiotic supplement formulations for veterinary use, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; veterinary preparations active in the microbiome space, namely, probiotic and prebiotic supplements; veterinary preparations for providing antibodies for the protection against disease; preparations for destroying parasitesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 20, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 20, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 20, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 18, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 18, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 10, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 9, 2024EX5GSOU EXTENSION 5 GRANTED—
Apr 9, 2024EXT5SOU EXTENSION 5 FILED—
Apr 9, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 6, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 4, 2023EX4GSOU EXTENSION 4 GRANTED—
Oct 4, 2023EXT4SOU EXTENSION 4 FILED—
Oct 4, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 8, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 6, 2023EX3GSOU EXTENSION 3 GRANTED—
Apr 6, 2023EXT3SOU EXTENSION 3 FILED—
Apr 6, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 7, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 5, 2022EX2GSOU EXTENSION 2 GRANTED—
Oct 5, 2022EXT2SOU EXTENSION 2 FILED—
Oct 5, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 9, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 7, 2022EX1GSOU EXTENSION 1 GRANTED—
Apr 7, 2022EXT1SOU EXTENSION 1 FILED—
Apr 7, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 4, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 4, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 4, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 12, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 17, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 17, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 28, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 14, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 14, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Jul 14, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 14, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 14, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 1, 2021DOCKASSIGNED TO EXAMINER—
Mar 24, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 2, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance